Doris Peterkin Email

Co-founder & CEO . OncoPep

Current Roles

Employees:
13
Revenue:
$1M
About
Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell focused technologies are designed to be used on their own or in combination with other immunotherapeutics.
OncoPep Address
222 3rd Street
Boston, MA
OncoPep Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.